Skip Navigation

Preparation of a manuscript


The following authorship form must be completed and should include the following:


Signatures from each author agreeing to their inclusion in the list of authors in order of appearance on the manuscript, along with a brief description of each author’s role in the study. Human Reproduction adheres strictly to the International Committee of Medical Journal Editors (ICMJE) guidelines regarding ‘Authorship and Contributorship’ (see All authors must indicate their individual contribution to the paper. Justification of authorship includes 1) substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data, 2) drafting the article or revising it critically for important intellectual content, and 3) final approval of the version to be published. All authors must meet contributions (1), (2) and (3). Authors’ roles must be detailed in the paper in a titled section immediately after the discussion.

Conflict of Interest

Human Reproduction is committed to ensuring that all papers submitted to the journal are treated in a fair and unbiased way. As such, authors must declare any interests that they (or others) could consider to lead to a perceived bias. These biases (or perceived biases) can be of a financial, personal or professional nature, including (but not restricted to):

  1. 1. financial competing interests, such as stock ownership, paid employment, board membership, patent application (pending and actual), research grants (from whatever source), travel grants and honoraria for speaking or participation at meetings and gifts;
  2. 2. personal competing interests, such as membership of lobbying organizations and relationships with editors of Human Reproduction;
  3. 3. professional competing interests, such as acting as an expert witness, membership of Government advisory board and organizations and funding bodies.

Competing interest statements should be included in an appropriate position in the manuscript.

Human Reproduction now uses the ICMJE uniform disclosure of conflict of interest form ( Each author declaring the existence of a conflict of interest on the author signature form must complete and sign an ICMJE disclosure form, which should be included with your original submission.

All authors must disclose any commercial or financial interest and/or any other relationships with pharmaceutical manufacturers.
Commercial Interest: any proprietary entity producing, re-selling, distributing or otherwise participating in or profiting from the distribution, promotion or sale of goods or services used by or on patients.
Financial interests/relationships: whereby an individual benefits by receiving salary, royalty intellectual property rights, consulting fees, honoraria, ownership interests (stocks, shares, etc) or other financial benefit. Financial benefits are usually, but not exclusively, associates with employment/management status, contractual work, consulting, teaching and speaking, advisory committee membership, review panel and board membership and other activities for which remuneration is expected or awarded. Declaration of such financial relationships covers the preceding 12 month period, and all such financial relationships of a spouse or partner.

Authorship Order: The order of authorship should be a joint decision of the co-authors, and should be agreed upon before submission to the journal. Changes to authorship (order or addition or removal of an author) after initial submission, must be agreed by all authors.

Joint First Authorship: A superscript identifier (Ϯ) and footnote declaring joint first authorship is allowed. The joint first authors should be the first names in the list of authors. A footnote containing the statement: " Ϯ The authors consider that the first two authors should be regarded as joint First Authors" will be added. Other statements concerning joint authorship will not be published. Joint senior/last authorship is not permitted.

* Note that it is the responsibility of the corresponding author to obtain permission to publish previously published material and submit with their manuscript the permission from the copyright holder.

It is a condition of publication that authors assign a 'licence to publish' to ESHRE. Upon acceptance, a 'licence to publish' form must be completed. Authors may use their own material in future publications provided the Journal is acknowledged as the original place of publication and permission agreed.

Human Reproduction no longer requires authors to cover the cost of printing colour figures. The use of colour in all figures including graphs and schematics is encouraged.

Page charges are NOT levied.


Human Reproduction authors have the option to publish their paper under the Oxford Open initiative; whereby, for a charge, their paper will be made freely available online immediately upon publication. After your manuscript is accepted the corresponding author will be required to accept a mandatory licence to publish agreement. As part of the licensing process you will be asked to indicate whether or not you wish to pay for open access. If you do not select the open access option, your paper will be published with standard subscription-based access and you will not be charged.

Oxford Open articles are published under Creative Commons licences. RCUK/Wellcome Trust funded authors publishing in Human Reproduction can use the Creative Commons Attribution licence (CC BY) for their articles.

All other authors may use Creative Commons Attribution Non-Commercial licence (CC BY-NC).

Please click here for more information about the Creative Commons licences.

You can pay Open Access charges using our Author Services site. This will enable you to pay online with a credit/debit card, or request an invoice by email or post. The applicable open access charges vary according to which Creative Commons licence you select. The open access charges are as follows:

Charges for CC BY: • Regular charge: £2125/ $3400/ €2763 Reduced Rate Developing country charge*: £1063/ $1700 / €1382 • Free Developing country charge *: £0 /$0 / €0

Charges for CC-BY-NC: • Regular charge: £1875/ $3000 / €2438 • Reduced Rate Developing country charge*: £938/ $1500 / €1219 • Free Developing country charge *: £0 /$0 / €0

*Visit our developing countries page (click here for a list of qualifying countries).

Please note that these charges are in addition to any colour charges that may apply.

Orders from the UK will be subject to the current UK VAT charge. For orders from the rest of the European Union, OUP will assume that the service is provided for business purposes. Please provide a VAT number for yourself or your institution and ensure you account for your own local VAT correctly.

Third-Party Content in Open Access papers

If you will be publishing your paper under an Open Access licence but it contains material for which you do not have Open Access re-use permissions, please state this clearly by supplying the following credit line alongside the material:

Title of content Author, Original publication, year of original publication, by permission of [rights holder]

This image/content is not covered by the terms of the Creative Commons licence of this publication. For permission to reuse, please contact the rights holder.


Each manuscript submission should be accompanied by a covering letter. This letter should be addressed to the Editor-in-Chief and should set out:

• The scientific question asked
• The principal new findings
• The significance of these findings to the field

Specific Instruction by manuscript type

Original Articles Opinions and Debates Case Reports Letters to the Editor

Instructions for the resubmission of revised manuscripts

General instructions for all manuscripts

  • Manuscript length Papers should be of a length appropriate for the amount of information they contain. Failure to restrict the length of manuscripts, especially Introduction and Discussion sections, can negatively influence the reviewers’ and the editor’s decisions.
  • Style Manuscripts should be written using clear and concise English, with English standard spelling and conventions. Non-English speaking authors are advised to enlist the assistance of a native English speaker, familiar with biomedical terminology. The editors reserve the right to return without review manuscripts that can not be adequately assessed due to a poor standard of English. For Biochemical and Bacterial terminology follow the International Union of Pure and Applied Chemistry (IUPAC) and International Union of Biochemistry and Molecular Biology (IUBMB) recommendations Genotypes must be italicized; phenotypes should not.
  • Units of measurement and abbreviations Units of measurement should be in Systéme International (SI) units and those recommended by the IUPAC should be used wherever possible. Standard units of measurements and chemical symbols of elements may be used without definition in the body of the paper. Abbreviations should be given in brackets after their first mention in the text, and used thereafter. For centrifugation rates give g values rather than rpm, as this will vary according to rotor diameter.
  • Format Text should be double spaced. A page number is required on each page in the top right corner. Number lines must be added and should be continuous. Avoid underlining. Differentiate clearly letters O, I and numbers 0, 1. Ensure unusual symbols are written clearly.

Crossref Funding Data Registry

In order to meet your funding requirements authors are required to name their funding sources, or state if there are none, during the submission process. For further information on this process or to find out more about the CHORUS initiative please click here.

Author Self-Archiving/Public Access policy from May 2005.
For information about Human Reproduction's policy, please visit our Author Self-Archiving policy page.